Product ID: SQMIG35I2220
Report ID:
SQMIG35I2220 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
61 |
Figures:
75
Botulinum Toxin Market Driver
The demand for botulinum toxin is increasing in minimally invasive to non-invasive cosmetic surgeries. Botulinum toxin is used to relax the muscles that cause wrinkles. It is also used to improve the appearance of skin irregularities. The most common areas treated with botulinum toxin are the forehead, eyes, and mouth. As a result, the number of cosmetic procedures performed each year is increasing. In 2020, Botulinum toxin became the the most popular non-surgical cosmetic surgery worldwide. Over 6.2 million Botox injections were administered by plastic surgeons throughout that year. Hyaluronic acid and hair removal were the second and third most prevalent types of non-surgical cosmetic procedures worldwide.
The availability of minimally invasive operations performed by highly qualified aesthetic surgeons has contributed to the increase in procedural volume. Furthermore, technological improvements, the introduction of low-cost aesthetic products, the aging population, and the increased incidence of aesthetic problems such as crow's foot and lateral canthal lines are all contributing to the global growth of the botulinum toxin market.
Botulinum Toxin Market Restraint
Side effects of botulinum toxin injection in patients, such as allergic reactions, rash, neck and back pain, difficulty swallowing, shortness of breath, and nausea are expected to hamper the growth of the botulinum toxin market. Potentially serious occurrences are the result of the toxin's systemic dissemination, which might cause botulism-like symptoms or systemic anaphylactic reactions. Cosmetic application of botulinum toxin seldom results in serious negative effects.
It has been observed that serious side effects are 33 times more common in therapeutic circumstances than in cosmetic cases. According to our estimates, the median botulinum toxin dose is four times larger in therapeutic instances than in cosmetic situations. They are defined as a life-threatening occurrence that necessitates intervention to prevent permanent damage and is connected with patient hospitalization or the extension of an existing hospitalization, as well as chronic or major disability. All these factors are likely to hamper the botulinum toxin market to some extent.
The botulinum toxin (BNT) procedures are expensive procedures, as well as low reimbursement coverage for treatments such as myobloc are deterring patient from opting the procedure. In addition, lack of inclusion of cosmetic procedure in insurance further stops people from avaialing the procedure performed, which further negatively affects the botulinum toxin market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONBotulinum Toxin Market size was valued at USD 5.8 billion in 2019 and is poised to grow from USD 6.47 billion in 2023 to USD 17.23 billion by 2031, growing at a CAGR of 11.5% in the forecast period (2024-2031).
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Product ID: SQMIG35I2220